Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomes
- 9 June 2020
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 302 (2) , 481-486
Abstract
Purpose To investigate the epidemiology, clinico-pathological characteristics and outcomes of patients diagnosed with malignant ovarian Sertoli-Leydig cell tumors (SLCTs) in comparison to granulosa cell tumors (GCTs). Methods The National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database were accessed and patients diagnosed with a malignant SLCT and GCT between 1988 and 2013 were selected. Demographic and clinico-pathological characteristics were compared using the Mann–Whitney and chi-square tests. Overall (OS) and cancer-specific survival (CSS) rates were estimated with the Kaplan–Meier method and compared with the log-rank test. Cox hazard models were constructed to control for confounders. Results A total of 175 and 1361 patients diagnosed with SLCT and GCT, respectively, were identified. Compared to patients with GCT, those with SLCT were younger (median age 32 vs. 51 years, p < 0.001) and more likely to present with larger tumors (median size 15 vs 9.5 cm, p < 0.001) confined to the ovary (77.5% vs 69.2%, p = 0.031). Patients with SLCTs had worse CSS compared to those with GCTs, p < 0.001 (5-year rate was 76.2% vs 90.7%). After controlling for the presence of extra-ovarian disease and tumor size (≤ 10 vs > 10 cm), SCLTs were associated with a worse cancer-specific mortality compared to GCTs. Conclusions SLCTs are extremely rare, commonly arise in premenopausal patients. They are associated with a poorer prognosis compared to GCT.Keywords
This publication has 23 references indexed in Scilit:
- Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumorsGynecologic Oncology, 2017
- Ovarian Sertoli–Leydig cell tumours: How typical is their typical presentation?Journal of Obstetrics and Gynaecology, 2017
- Ovarian Sex Cord-Stromal TumorsJournal of Oncology Practice, 2016
- Sertoli–Leydig cell tumors: current status of surgical management: literature review and proposal of treatmentGynecological Endocrinology, 2013
- A clinicopathological analysis of 40 cases of ovarian Sertoli–Leydig cell tumorsGynecologic Oncology, 2012
- Sertoli‐Leydig cell tumor of the ovary: Analysis of a single institution databaseJournal of Obstetrics and Gynaecology Research, 2012
- Ovarian Sertoli-Leydig cell tumors. A retrospective MITO studyGynecologic Oncology, 2012
- Management of Ovarian Stromal Cell TumorsJournal of Clinical Oncology, 2007
- Ovarian Sertoli - Leydig cell tumorsAmerican Journal of Surgical Pathology, 1985
- Ovarian Sertoli-Leydig cell tumors with heterologous elements I. Gastrointestinal epithelium and carcinoid: A clinicopathologic analysis of thirty-six casesCancer, 1982